- Home
- NRDY vs INMB Comparison
NRDY vs INMB Comparison
Compare NRDY & INMB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NRDY
- INMB
- Stock Information
- Founded
- NRDY 2007
- INMB 2015
- Country
- NRDY United States
- INMB United States
- Employees
- NRDY N/A
- INMB N/A
- Industry
- NRDY Computer Software: Prepackaged Software
- INMB Biotechnology: Pharmaceutical Preparations
- Sector
- NRDY Technology
- INMB Health Care
- Exchange
- NRDY Nasdaq
- INMB Nasdaq
- Market Cap
- NRDY 188.8M
- INMB 176.5M
- IPO Year
- NRDY N/A
- INMB 2019
- Fundamental
- Price
- NRDY $1.73
- INMB $7.27
- Analyst Decision
- NRDY Hold
- INMB Strong Buy
- Analyst Count
- NRDY 8
- INMB 3
- Target Price
- NRDY $1.90
- INMB $24.33
- AVG Volume (30 Days)
- NRDY 609.9K
- INMB 285.1K
- Earning Date
- NRDY 05-08-2025
- INMB 05-08-2025
- Dividend Yield
- NRDY N/A
- INMB N/A
- EPS Growth
- NRDY N/A
- INMB N/A
- EPS
- NRDY N/A
- INMB N/A
- Revenue
- NRDY $184,099,000.00
- INMB $50,000.00
- Revenue This Year
- NRDY $4.13
- INMB N/A
- Revenue Next Year
- NRDY $9.80
- INMB $43,178.43
- P/E Ratio
- NRDY N/A
- INMB N/A
- Revenue Growth
- NRDY N/A
- INMB N/A
- 52 Week Low
- NRDY $0.73
- INMB $4.32
- 52 Week High
- NRDY $2.18
- INMB $10.50
- Technical
- Relative Strength Index (RSI)
- NRDY 56.32
- INMB 46.09
- Support Level
- NRDY $1.51
- INMB $7.25
- Resistance Level
- NRDY $1.80
- INMB $8.06
- Average True Range (ATR)
- NRDY 0.09
- INMB 0.45
- MACD
- NRDY 0.00
- INMB -0.03
- Stochastic Oscillator
- NRDY 67.19
- INMB 21.85
About NRDY Nerdy Inc.
Nerdy Inc is a curated direct-to-consumer platform for live online learning. Its proprietary platform leverages technology, including artificial intelligence ("AI"), to connect students, users, parents, guardians, and purchasers of all ages to tutors, instructors, subject matter experts, educators, and other professionals. The company provides learning experiences across numerous subjects and multiple formats, including one-on-one instruction, small group tutoring, large format classes, tutor chat, essay review, adaptive assessments, and self-study tools. The company generates revenue by selling services to learners and institutions for one-on-one instruction and small group tutoring.
About INMB INmune Bio Inc. Common stock
INmune Bio Inc is a clinical-stage biotechnology company. It is engaged in the development of new immunotherapies that reprogram a patient's innate immune system to allow immune system to fight cancer. The company's pipeline products includeINKmune, INBO3, XPro1595, LIVNate, and others.